Balsalazide disodium salt dihydrate
CAS No. 150399-21-6
Balsalazide disodium salt dihydrate( Balsalazide Disodium | balsalazide | BX 661A | Colazal | Colazide )
Catalog No. M18055 CAS No. 150399-21-6
Balsalazide is an anti-inflammatory compound used in the treatment of Inflammatory Bowel Disease.Balsalazide is a new 5-aminosalicylic acid (5-ASA) containing prodrug.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 5MG | 37 | In Stock |
|
| 10MG | 56 | In Stock |
|
| 25MG | 100 | In Stock |
|
| 50MG | 147 | In Stock |
|
| 100MG | 222 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBalsalazide disodium salt dihydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionBalsalazide is an anti-inflammatory compound used in the treatment of Inflammatory Bowel Disease.Balsalazide is a new 5-aminosalicylic acid (5-ASA) containing prodrug.
-
DescriptionBalsalazide Disodium is the disodium salt form of balsalazide, an aminosalicylate and oral prodrug that is enzymatically cleaved in the colon to produce the anti-inflammatory agent mesalazine. Mesalazine acts locally on the mucosa of the colon where it diminishes inflammation by blocking the production of arachidonic acid metabolites and other inflammatory agents. Balsalazide disodium is used to treat chronic inflammatory bowel disease.(In Vivo):At the endpoint, the protein production of MIP-1β, MCP-1, IL-6, and IL-10 in the colon tissues decrease in concordance with the plasma concentrations of the cytokines. The drug-treated groups reveal lower expression of p-STAT3 compared to the CAC group. In addition, BCL2 decreases and BAX increases markedly in the BSZ+VSL#3 group. Balsalazide is a new 5-aminosalicylic acid (5-ASA) containing prodrug.
-
In Vitro——
-
In VivoAt the endpoint, the protein production of MIP-1β, MCP-1, IL-6, and IL-10 in the colon tissues decrease in concordance with the plasma concentrations of the cytokines. The drug-treated groups reveal lower expression of p-STAT3 compared to the CAC group. In addition, BCL2 decreases and BAX increases markedly in the BSZ+VSL#3 group. Balsalazide is a new 5-aminosalicylic acid (5-ASA) containing prodrug.
-
SynonymsBalsalazide Disodium | balsalazide | BX 661A | Colazal | Colazide
-
PathwayOthers
-
TargetOther Targets
-
RecptorSTAT
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number150399-21-6
-
Formula Weight437.31
-
Molecular FormulaC17H17N3Na2O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (285.84 mM)
-
SMILES[Na+].[Na+].O.O.O=C([O-])c1cc(ccc1O)/N=N/c2ccc(cc2)C(=O)NCCC([O-])=O
-
Chemical Name5-[4-(2-Carboxyethylcarbamoyl)phenylazo]salicylic Acid Disodium Salt Dihydrate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kruis W, et al. Gut, 2001. 49(6): p. 783-789.
molnova catalog
related products
-
IFN alpha-IFNAR-IN-1...
IFN alpha-IFNAR-IN-1 hydrochloride is an inhibitor of the interaction between IFN-α and IFNAR. IFN alpha-IFNAR-IN-1 hydrochloride inhibits MVA-induced IFN-α responses by BM-pDCs with IC50 of 2-8 μM.
-
p-Hydroxybenzaldehyd...
4-Hydroxybenzaldehyde shows an inhibitory effect on the GABA transaminase to contribute to an antiepileptic and anticonvulsive activity.
-
Glyoxylic acid monoh...
Glyoxylic acid or oxoacetic acid is an organic compound that is both an aldehyde and a carboxylic acid.It is an intermediate of the glyoxylate cycle which enables certain organisms to convert fatty acids into carbohydrates. The conjugate base of glyoxylic acid is known as glyoxylate.
Cart
sales@molnova.com